Suppr超能文献

实体器官移植后骨质疏松症的研究现状:发病机制与管理

Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

作者信息

Lan Gong-bin, Xie Xu-biao, Peng Long-kai, Liu Lei, Song Lei, Dai He-long

机构信息

Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

出版信息

Biomed Res Int. 2015;2015:413169. doi: 10.1155/2015/413169. Epub 2015 Nov 15.

Abstract

Improved survival following organ transplantation has brought to the forefront some long-term complications, among which osteoporosis and associated fractures are the major ones that adversely affect the quality of life in recipients. The pathogenesis of osteoporosis in transplant recipients is complex and multifactorial which may be related to increased bone resorption, decreased bone formation, or both. Studies have shown that the preexisting underlying metabolic bone disorders and the use of immunosuppressive agents are the major risk factors for osteoporosis and fractures after organ transplantation. And rapid bone loss usually occurs in the first 6-12 months with a significant increase in fracture risk. This paper will provide an updated review on the possible pathogenesis of posttransplant osteoporosis and fractures, the natural history, and the current prevention and treatment strategies concerning different types of organ transplantation.

摘要

器官移植后生存率的提高使一些长期并发症成为关注焦点,其中骨质疏松症及相关骨折是严重影响受者生活质量的主要并发症。移植受者骨质疏松症的发病机制复杂且具有多因素性,可能与骨吸收增加、骨形成减少或两者均有关。研究表明,移植前存在的潜在代谢性骨病以及免疫抑制剂的使用是器官移植后发生骨质疏松症和骨折的主要危险因素。而且快速骨质流失通常发生在最初的6 - 12个月,骨折风险显著增加。本文将对移植后骨质疏松症和骨折的可能发病机制、自然病程以及当前针对不同类型器官移植的预防和治疗策略进行更新综述。

相似文献

1
Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.
Biomed Res Int. 2015;2015:413169. doi: 10.1155/2015/413169. Epub 2015 Nov 15.
2
Osteoporosis after solid organ transplantation.
Minerva Endocrinol. 2012 Sep;37(3):221-31.
3
Transplantation osteoporosis.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):783-92. doi: 10.1590/s0004-27302006000400023.
4
Approach to the patient with transplantation-related bone loss.
J Clin Endocrinol Metab. 2009 May;94(5):1483-90. doi: 10.1210/jc.2009-0205.
5
[Post-transplantation osteoporosis].
Medicina (B Aires). 1999;59(6):777-86.
6
Management of bone loss after organ transplantation.
J Bone Miner Res. 2004 Dec;19(12):1919-32. doi: 10.1359/JBMR.040912. Epub 2004 Sep 20.
7
Osteoporosis after organ transplantation.
Am J Med. 1998 May;104(5):459-69. doi: 10.1016/s0002-9343(98)00081-3.
8
Bone disease after transplantation: osteoporosis and fractures risk.
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):484-92. doi: 10.1590/0004-2730000003343.
10
Osteoporosis after solid organ transplantation.
J Clin Endocrinol Metab. 2005 Apr;90(4):2456-65. doi: 10.1210/jc.2004-1978. Epub 2004 Dec 28.

引用本文的文献

1
Side Effects of Immunosuppressant Drugs After Liver Transplant.
Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342.
3
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.
Endocrinol Metab (Seoul). 2024 Apr;39(2):267-282. doi: 10.3803/EnM.2024.1939. Epub 2024 Apr 25.
4
Increase in lumbar spine but not distal radius bone mineral density in adults after pancreas kidney transplantation.
Bone Rep. 2024 Apr 18;21:101764. doi: 10.1016/j.bonr.2024.101764. eCollection 2024 Jun.
6
MicroRNA Expression Profile in Patients Admitted to ICU as Novel and Reliable Approach for Diagnostic and Therapeutic Purposes.
Mol Biotechnol. 2024 Jun;66(6):1357-1375. doi: 10.1007/s12033-023-00767-2. Epub 2023 Jun 14.
7
High risk of osteoporosis and fracture following solid organ transplantation: a population-based study.
Front Endocrinol (Lausanne). 2023 May 23;14:1167574. doi: 10.3389/fendo.2023.1167574. eCollection 2023.
8
Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
Osteoporos Int. 2023 Jun;34(6):1011-1035. doi: 10.1007/s00198-022-06640-3. Epub 2023 Apr 4.
10
Mineral and bone disorder after kidney transplantation (KTx).
J Bras Nefrol. 2021 Dec 3;43(4 Suppl 1):674-679. doi: 10.1590/2175-8239-JBN-2021-S113. eCollection 2021.

本文引用的文献

1
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.
Endocrine. 2015 Aug;49(3):620-7. doi: 10.1007/s12020-014-0506-5. Epub 2015 Feb 4.
6
Incidence of fractures after cardiac and lung transplantation: a single center experience.
J Osteoporos. 2014;2014:573041. doi: 10.1155/2014/573041. Epub 2014 Apr 22.
7
Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study.
Mayo Clin Proc. 2014 Jul;89(7):888-95. doi: 10.1016/j.mayocp.2014.02.017. Epub 2014 May 5.
9
Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim.
Calcif Tissue Int. 2014 Jun;94(6):640-7. doi: 10.1007/s00223-014-9847-6.
10
Bone and mineral disorders after kidney transplantation: therapeutic strategies.
Transplant Rev (Orlando). 2014 Apr;28(2):56-62. doi: 10.1016/j.trre.2013.12.003. Epub 2013 Dec 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验